The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).
 
Xue Meng
No Relationships to Disclose
 
Anping Zheng
No Relationships to Disclose
 
Jun Wang
No Relationships to Disclose
 
Jianhua Wang
No Relationships to Disclose
 
Guang Li
No Relationships to Disclose
 
Jun Zhu
No Relationships to Disclose
 
Hu Ma
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Anhui Shi
No Relationships to Disclose
 
Chunhua Dai
No Relationships to Disclose
 
Senxiang Yan
No Relationships to Disclose
 
Buhai Wang
No Relationships to Disclose
 
Zhongyu Qu
No Relationships to Disclose
 
Chun Han
No Relationships to Disclose
 
Xindong Sun
No Relationships to Disclose
 
Ming Ye
No Relationships to Disclose
 
Ruitai Fan
No Relationships to Disclose
 
Ni yazi Huerxidan
No Relationships to Disclose
 
Xiaohong Wang
No Relationships to Disclose
 
Jinming Yu
No Relationships to Disclose